Literature DB >> 33326097

Ewing Sarcoma-Specific (Re)expression Models.

Maximilian M L Knott1,2, Florencia Cidre-Aranaz3,4,5.   

Abstract

Gene expression and knockdown systems are powerful tools to study the function of single genes and their pathway interaction. Plasmid transfection and viral transduction have revolutionized the field of molecular biology and paved the ground for various gene-editing strategies such as TALEN, zinc finger nucleases, and ultimately CRISPR. In Ewing sarcoma (EwS), almost as many genes are repressed by the expression of EWSR1-FLI1 as are upregulated by the fusion oncogene. Here we present a useful point-to-point protocol for the generation of transgene expression systems in EwS that allow (conditional) reexpression of a gene of interest. We provide an extensive instruction on molecular cloning, plasmid generation, viral transduction, and expression validation. Finally, we address common problems and highlight potential pitfalls, which can easily be avoided by thoughtful guidance.

Entities:  

Keywords:  Enhancer; Ewing sarcoma; Fusion-driven sarcoma; Gene expression; Inducible vector; Microsatellites; Overexpression; Promoter

Mesh:

Substances:

Year:  2021        PMID: 33326097     DOI: 10.1007/978-1-0716-1020-6_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

1.  Construction of hybrid viruses containing SV40 and lambda phage DNA segments and their propagation in cultured monkey cells.

Authors:  S P Goff; P Berg
Journal:  Cell       Date:  1976-12       Impact factor: 41.582

2.  Plasmid vector pBR322 and its special-purpose derivatives--a review.

Authors:  P Balbás; X Soberón; E Merino; M Zurita; H Lomeli; F Valle; N Flores; F Bolivar
Journal:  Gene       Date:  1986       Impact factor: 3.688

3.  Engineered immune cells as highly sensitive cancer diagnostics.

Authors:  Amin Aalipour; Hui-Yen Chuang; Surya Murty; Aloma L D'Souza; Seung-Min Park; Gunsagar S Gulati; Chirag B Patel; Corinne Beinat; Federico Simonetta; Ivana Martinić; Gayatri Gowrishankar; Elise R Robinson; Eamon Aalipour; Zahra Zhian; Sanjiv S Gambhir
Journal:  Nat Biotechnol       Date:  2019-03-18       Impact factor: 54.908

Review 4.  Recombinant cloning strategies for protein expression.

Authors:  Patrick Hn Celie; Annabel Ha Parret; Anastassis Perrakis
Journal:  Curr Opin Struct Biol       Date:  2016-07-05       Impact factor: 6.809

5.  Construction of biologically functional bacterial plasmids in vitro.

Authors:  S N Cohen; A C Chang; H W Boyer; R B Helling
Journal:  Proc Natl Acad Sci U S A       Date:  1973-11       Impact factor: 11.205

6.  Suppression of intratumoral CCL22 by type i interferon inhibits migration of regulatory T cells and blocks cancer progression.

Authors:  David Anz; Moritz Rapp; Stephan Eiber; Viktor H Koelzer; Raffael Thaler; Sascha Haubner; Max Knott; Sarah Nagel; Michaela Golic; Gabriela M Wiedemann; Franz Bauernfeind; Cornelia Wurzenberger; Veit Hornung; Christoph Scholz; Doris Mayr; Simon Rothenfusser; Stefan Endres; Carole Bourquin
Journal:  Cancer Res       Date:  2015-10-02       Impact factor: 12.701

Review 7.  Gene therapy comes of age.

Authors:  Cynthia E Dunbar; Katherine A High; J Keith Joung; Donald B Kohn; Keiya Ozawa; Michel Sadelain
Journal:  Science       Date:  2018-01-12       Impact factor: 47.728

Review 8.  Tetracycline antibiotics impair mitochondrial function and its experimental use confounds research.

Authors:  Iliana A Chatzispyrou; Ntsiki M Held; Laurent Mouchiroud; Johan Auwerx; Riekelt H Houtkooper
Journal:  Cancer Res       Date:  2015-10-16       Impact factor: 12.701

9.  Doxycycline alters metabolism and proliferation of human cell lines.

Authors:  Ethan Ahler; William J Sullivan; Ashley Cass; Daniel Braas; Autumn G York; Steven J Bensinger; Thomas G Graeber; Heather R Christofk
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

10.  The Addgene repository: an international nonprofit plasmid and data resource.

Authors:  Joanne Kamens
Journal:  Nucleic Acids Res       Date:  2014-11-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.